Canadian Biomarker Integration Network for Depression Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This study is a pilot to assess feasibility of the protocol in patients and controls across six participating sites. The goal is to identify biological markers (biomarkers)that can be measured at baseline or early in treatment to predict treatment outcome in individual patients with Major Depressive Disorder (MDD). Biomarkers of interest will be clinical (using interview and self-report measures), molecular (from blood samples) and neurobiological (using neuroimaging and EEG).
Epistemonikos ID: 6085a371c24b26198e027d355f7a6b578a9dec4f
First added on: May 11, 2024